305 related articles for article (PubMed ID: 33019981)
1. No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
Ubachs J; Koole SN; Lahaye M; Fabris C; Bruijs L; Schagen van Leeuwen J; Schreuder HWR; Hermans RH; de Hingh IH; van der Velden J; Arts HJ; van Ham M; van Dam P; Vuylsteke P; Bastings J; Kruitwagen RFPM; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T; Sonke GS; van Driel WJ
Gynecol Oncol; 2020 Dec; 159(3):706-711. PubMed ID: 33019981
[TBL] [Abstract][Full Text] [Related]
2. Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer.
Koole SN; Bruijs L; Fabris C; Sikorska K; Engbersen M; Schagen van Leeuwen JH; Schreuder HWR; Hermans RH; van der Velden J; Arts HJG; van Ham M; Van Dam P; Vuylsteke P; Lahaye M; Sonke G; Driel WV
Int J Gynecol Cancer; 2020 Dec; 30(12):1928-1934. PubMed ID: 33046576
[TBL] [Abstract][Full Text] [Related]
3. Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation.
Fadadu PP; Polen-De CL; McGree ME; Weaver AL; Moynagh MR; Takahashi N; Langstraat CL; Cliby WA; Kumar A
Gynecol Oncol; 2021 Jan; 160(1):40-44. PubMed ID: 33109391
[TBL] [Abstract][Full Text] [Related]
4. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
Huang CY; Sun FJ; Lee J
Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
[TBL] [Abstract][Full Text] [Related]
6. Association between CT-based body composition assessment and patient outcomes during neoadjuvant chemotherapy for epithelial ovarian cancer.
Wood N; Morton M; Shah SN; Yao M; Barnard H; Tewari S; Suresh A; Kollikonda S; AlHilli MM
Gynecol Oncol; 2023 Feb; 169():55-63. PubMed ID: 36508759
[TBL] [Abstract][Full Text] [Related]
7. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
[TBL] [Abstract][Full Text] [Related]
8. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer.
van der Zanden V; van Soolingen NJ; Viddeleer AR; Trum JW; Amant F; Mourits MJE; Portielje JEA; van den Bos F; de Kroon CD; Kagie MJ; Oei SA; Baalbergen A; van Haaften-de Jong ALD; Houtsma D; van Munster BC; Souwer ETD
Gynecol Oncol; 2021 Aug; 162(2):360-367. PubMed ID: 34112514
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer.
Lee J; Liu SH; Dai KY; Huang YM; Li CJ; Chen JC; Leu YS; Liu CJ; Chen YJ
Laryngoscope; 2021 May; 131(5):E1530-E1538. PubMed ID: 33135827
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy.
Fukushima H; Nakanishi Y; Kataoka M; Tobisu KI; Koga F
Clin Genitourin Cancer; 2017 Apr; 15(2):e229-e238. PubMed ID: 27601279
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia as a Predictor of Prognosis in Early Stage Ovarian Cancer.
Chae SH; Lee C; Yoon SH; Shim SH; Lee SJ; Kim SN; Chung S; Lee JY
J Korean Med Sci; 2021 Jan; 36(1):e2. PubMed ID: 33398939
[TBL] [Abstract][Full Text] [Related]
13. Loss of skeletal muscle density during neoadjuvant chemotherapy in older women with advanced stage ovarian cancer is associated with postoperative complications.
van der Zanden V; van Soolingen NJ; Viddeleer AR; Trum JW; Amant F; Mourits MJE; Portielje JEA; Baalbergen A; Souwer ETD; van Munster BC
Eur J Surg Oncol; 2022 Apr; 48(4):896-902. PubMed ID: 34756760
[TBL] [Abstract][Full Text] [Related]
14. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
[TBL] [Abstract][Full Text] [Related]
15. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
[TBL] [Abstract][Full Text] [Related]
16. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
[TBL] [Abstract][Full Text] [Related]
18. Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma.
Ishihara H; Takagi T; Kondo T; Fukuda H; Yoshida K; Iizuka J; Tanabe K
Target Oncol; 2018 Dec; 13(6):745-755. PubMed ID: 30328067
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery.
Son JH; Lee JH; Jung JA; Kong TW; Paek J; Chang SJ; Ryu HS
Gynecol Oncol; 2018 Oct; 151(1):32-38. PubMed ID: 30122310
[TBL] [Abstract][Full Text] [Related]
20. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
